Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dry eye moves beyond palliative therapy.

John D Sheppard1

  • 1Eastern Virginia Medical School, USA.

Managed Care (Langhorne, Pa.)
|January 16, 2004
PubMed
Summary
This summary is machine-generated.

Keratoconjunctivitis sicca, or dry eye syndrome, is an inflammatory ocular surface condition. Effective therapy for dry eye offers significant potential for cost savings.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparing Global Operating Room Waste Generated From Cataract, Corneal, and Conjunctival Surgeries.

Cornea·2026
Same author

Ocular surface disease following LASIK and cataract surgery: a review of their interrelated complications.

Frontiers in medicine·2026
Same author

Corneal Staining Responder Analysis: A Clinically Meaningful Dry Eye Outcome.

Ophthalmology·2025
Same author

Pooled results from two pivotal randomized controlled clinical trials: ESSENCE-1 and ESSENCE-2 to assess efficacy and safety of a water-free ciclosporin 0.1% formulation for the treatment of dry eye disease.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2024
Same author

Perfluorohexyloctane ophthalmic solution for dry eye disease: pooled analysis of two phase 3 clinical trials.

Frontiers in ophthalmology·2024
Same author

Impact of Neurostimulation, Immunomodulation, Topical Medication Application, and Surgical Reconstruction on Corneal Nerve Function and Regeneration.

Eye & contact lens·2024
Same journal

Thanks to CMS Rule Change, MA Takes SDOH to a Whole New Level.

Managed care (Langhorne, Pa.)·2019
Same journal

Hail, Not Frail! MA's Wellness Reach Expands.

Managed care (Langhorne, Pa.)·2019
Same journal

To Be Continued:The Search for a Cure for HIV.

Managed care (Langhorne, Pa.)·2019
Same journal

Once-a-day HIV Treatment: Pricey But Perhaps Worth It.

Managed care (Langhorne, Pa.)·2019
Same journal

In Trump, HIV/AIDS Groups Find an Ally Who's Tough To Love.

Managed care (Langhorne, Pa.)·2019
Same journal

Air Ambulance Turbulence: Consolidation, Cost Shifting, and Surprise Billing.

Managed care (Langhorne, Pa.)·2019
See all related articles

Area of Science:

  • Ophthalmology
  • Immunology

Background:

  • Keratoconjunctivitis sicca (dry eye syndrome) involves ocular surface inflammation and lacrimal gland dysfunction.
  • Understanding the causes of dry eye has advanced therapeutic options.

Purpose of the Study:

  • To highlight the link between dry eye etiology and effective treatment.
  • To underscore the economic benefits of managing dry eye.

Main Methods:

  • Review of current understanding of dry eye pathogenesis.
  • Analysis of therapeutic outcomes and cost-effectiveness.

Main Results:

  • Emerging knowledge of dry eye etiology facilitates targeted and effective treatments.
  • Successful management of dry eye syndrome can lead to substantial cost reductions.

Related Experiment Videos

Conclusions:

  • Effective therapy for dry eye syndrome is achievable with current knowledge.
  • Controlling dry eye presents significant opportunities for healthcare economic savings.